Cervical organoids go viral

Sara Sartini; Alice Soragni

doi:10.1016/j.stem.2021.07.007

Cervical organoids go viral

Cell Stem Cell. 2021 Aug 5;28(8):1337-1338. doi: 10.1016/j.stem.2021.07.007.

Authors

Sara Sartini¹, Alice Soragni²

Affiliations

¹ Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
² Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: alices@mednet.ucla.edu.

PMID: 34358436
DOI: 10.1016/j.stem.2021.07.007

Abstract

In this issue of Cell Stem Cell, Lõhmussaar et al. (2021) describe a versatile platform for generating long-term patient-derived organoids from hysterectomies and Pap brush cells. They establish malignant and benign cervix tissue organoids from both endo- and ectocervix that have applications ranging from precision medicine to infection modeling.

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Cervix Uteri*
Female
Humans
Organoids*
Precision Medicine

Grants and funding

R01 CA240718/CA/NCI NIH HHS/United States